ESMO25 Breast Cancer Highlights
2025 ESMO Prostate Cancer Highlights
2025 ESMO Kidney Cancer Highlights
2025 ESMO Bladder Cancer Highlights
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
FLAURA2 Lung Cancer Study Presented by Pasi Jänne, MD, PhD
The Evolution of Cancer Predisposition Guidelines for Children
Updates in Breast Cancer Surgery
Physiatric Approach to Pain in Breast Cancer
Low-Dose Radiation Therapy for Arthritis
Modern Management of Borderline Resectable Pancreatic Cancer
Treatment Guideline: Inavolisib, Palbociclib, and Fulvestrant for Hormone Receptor-Positive/HER2-negative Metastatic Breast Cancer
Treatment Guideline: Ovarian Function Suppression and Estradiol Monitoring in Early-Stage Estrogen Receptor-Positive Breast Cancer
Tip Sheet: Adrenal Insufficiency in Breast Cancer Patients
AACR Pediatric Special Conference in Cancer Research
Is Subcutaneous Immunotherapy Ready for Prime Time? Join the June 23 webinar
Join Roswell Park Expert at 2nd Annual Upstate Cancer Symposium June 21
Triplet Therapy Shows Promise for BPDCN, a rare blood cancer, in Dana-Farber Study
Childhood leukemia care puts one in three families at risk of poverty
Dana-Farber Cancer Institute drives deep remissions in Waldenstrom’s with targeted, time limited therapies
Chemo-free Regimens Show Promise, Could Redefine Care for B-Cell Lymphomas
Phase III VERONA trial results show potential benefit for some groups with myelodysplastic syndrome (MDS)
Sickle-cell disease associated with early onset of clonal hematopoiesis, a precancerous condition
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
